Related Experiment Video
Updated: Jul 3, 2026

08:48
Flow Cytometric Analysis of Biomarkers for Detecting Human Sperm Functional Defects
Published on: April 21, 2022
Comparing flow cytometry and fluorescence microscopy for analyzing human sperm DNA fragmentation by TUNEL labeling
Monica Muratori1, Gianni Forti, Elisabetta Baldi
1Andrology Unit, Department of Clinical Physiopathology, Center for Research Transfer and High Education DeNothe, University of Florence, I-50139 Firenze, Italy.
Summary
Flow cytometry (FCM) and fluorescence microscopy (FM) yield conflicting results for sperm DNA fragmentation detection. FCM may underestimate fragmentation due to M540 bodies and varying sperm populations, requiring further investigation for accurate assessment.
Area of Science:
- Reproductive Biology
- Sperm Analysis
- Biotechnology
Background:
- Conflicting results exist comparing flow cytometry (FCM) and fluorescence microscopy (FM) for sperm DNA fragmentation detection using the TUNEL assay.
- While FM limitations are known, FCM's inability to distinguish morphologically similar cells, like M540 bodies, introduces less-explored biases.
- These biases, including M540 bodies and dual sperm populations, can lead to underestimation of sperm DNA fragmentation by FCM.
Discussion:
- The study discusses potential variables affecting TUNEL assay results in both FM and FCM.
- It highlights the need to address FCM's limitations in recognizing non-sperm structures and varying sperm nuclear staining.
- The discrepancies between FM and FCM findings, even after accounting for known biases, warrant further investigation.
Key Insights:
- FCM may underestimate sperm DNA fragmentation due to the inclusion of M540 bodies and the presence of two sperm populations with different nuclear staining.
- The morphological analysis limitations of FCM are a significant factor contributing to discrepancies with FM.
- Accurate sperm DNA fragmentation assessment requires addressing these specific technical challenges in FCM.
Outlook:
- Further research is needed to reconcile the discrepancies between FM and FCM for sperm DNA fragmentation analysis.
- Standardization of FCM protocols to exclude M540 bodies and account for sperm population variations is crucial.
- Developing robust methods to improve the accuracy and reliability of FCM in sperm DNA fragmentation testing is essential for clinical applications.

